ArticleFrontiers in oncology2026
A real-world data study on long-course venetoclax combined with hypomethylating agents in unfit patients.
Chen Cao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it